Update: Temple Health and Keystone First Family Health Plans have reached a new contract agreement. 

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial (NAIL-IT)

view all Clinical Trials

Overview

Evaluation of safety and thrombolytic effect of ascending doses of TS23 in subjects with intermediate-risk (sub-massive) acute pulmonary embolism (PE).

Clinical Trial Information

Protocol

TIRB# 30780

Phase

2

Condition(s)

Pulmonary Embolism, Pulmonary Vascular Disease

Investigator

Parth Rali, MD

Coordinator

Kim Selwood

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

Evaluation of the Safety and Thrombolytic Effects of Ascending Doses of TS23 in Subjects With Intermediate-Risk (Sub-Massive) Acute Pulmonary Embolism